Plain-English translation of NCT07614321 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a medication called silodosin can help treat bladder and urinary symptoms in women who have multiple sclerosis. Many people with MS struggle with urinary problems, and researchers want to see if this medication — which is already used to treat similar symptoms in other conditions — might help. The study will compare the medication to a placebo (a pill that looks identical but contains no active drug) to find out if it really works.
Women with multiple sclerosis often experience uncomfortable and disruptive bladder symptoms, but treatment options are limited. This study exists to find out whether this medication could be a safe and effective way to help manage these symptoms and improve quality of life.
You likely qualify if…
You likely don't qualify if…
You would take either the medication or a placebo pill once daily for 8 weeks. You would visit the clinic twice — once before starting the pills and again after 8 weeks — for questionnaires about your symptoms and some tests to measure how well your bladder is working. The visits help researchers understand whether the treatment is helping.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States